Treatment for Patients with Significant Typhoid Titers

First-Line Treatment Options

The American College of Physicians recommends azithromycin as the first-line treatment for patients with significant typhoid titers, particularly in areas with high fluoroquinolone resistance, with a dose of 500 mg once daily for 7-14 days 1, 2
Azithromycin demonstrates superior outcomes with lower risk of clinical failure and shorter hospital stays compared to fluoroquinolones for uncomplicated typhoid fever 1
The Infectious Diseases Society of America recommends azithromycin for adults at a dose of 500 mg once daily for 7-14 days 1, 2
For children, the recommended dose is 20 mg/kg/day (maximum 1g/day) for 7-14 days 1

For fully susceptible S. typhi, the Centers for Disease Control and Prevention suggests fluoroquinolones remain effective, but azithromycin is still a strong alternative 1, 2
For multidrug-resistant strains, the World Health Organization recommends azithromycin or ceftriaxone 1
For quinolone-resistant strains, the American College of Physicians recommends azithromycin as the preferred first-line therapy 1

Ceftriaxone is recommended for severe cases requiring parenteral therapy, at a dose of 1-2g IV/IM daily for adults or 50-80 mg/kg/day for children (maximum 2g/day) for 5-7 days 3
Once clinical improvement occurs with IV therapy, transition to oral azithromycin may be considered 3

Blood cultures should be obtained before starting antibiotics when possible, as they have the highest yield within the first week of symptom onset 1, 3
Complications of typhoid fever occur in 10-15% of patients and are more likely if duration of illness exceeds 2 weeks 1
In severe cases with intestinal perforation, surgical intervention is recommended 4, 5
Simple excision and closure of small perforations has been reported in up to 88.2% of cases with intestinal perforation 4

Monitor for clinical response, with expected fever clearance within 4-5 days of appropriate therapy 2
Watch for potential drug interactions with azithromycin 2
Common adverse effects of azithromycin include gastrointestinal symptoms: nausea, vomiting, abdominal pain, and diarrhea 2

Typhoid vaccination provides incomplete protection and does not protect against paratyphoid 1, 2
The Centers for Disease Control and Prevention recommends vaccination for travelers to areas where a recognized risk of exposure to typhoid exists 6
Hand hygiene and appropriate food safety practices are essential preventive measures 7

Do not discontinue treatment prematurely; complete the full course of antibiotics to prevent relapse 1
Do not delay surgical intervention in cases with intestinal perforation 4, 5
Be aware that increasing resistance to fluoroquinolones has been observed, particularly among travelers to South and Southeast Asia 2